4.5 Letter

Is recombinant tissue plasminogen activator treatment a safe choice in very and extremely preterm infants with intracardiac thrombosis?

Journal

ARCHIVES OF DISEASE IN CHILDHOOD
Volume 107, Issue 8, Pages 772-775

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/archdischild-2022-323789

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available